Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Drug Deliv Transl Res. 2016 Apr;6(2):132–147. doi: 10.1007/s13346-015-0234-2

Figure 7.

Figure 7

(Top) Schematic diagram of theranostic approach for osteoarthritis-type II collagen antibodies-targeted fluorescent nanosomes. These nanosomes bind on damaged cartilage in an OA animal model, providing a traceable fluorescent signal and delivering therapeutic agents.[2] (Bottom) In a spontaneous OA model in guinea pigs, older animal showed higher accumulation of immunoliposomes. Reproduced with permission from Elsevier. [3]